Core Viewpoint - The company, Boshi Co., Ltd. (002698), has made significant investments in three advanced medical robotic projects, emphasizing the importance of artificial intelligence in enhancing accuracy and efficiency in surgical procedures [1] Group 1: Investment Projects - The company has invested in three key projects: 1. Harbin Sizerui Intelligent Medical Equipment Co., Ltd. for minimally invasive laparoscopic surgical robots 2. Jiangsu Ruil Medical Technology Co., Ltd. for stereotactic radiosurgery robots 3. Suzhou Zhuzheng Robotics Co., Ltd. for remote-assisted pedicle screw implantation robots [1] - These projects are part of the company's strategy in the high-end medical diagnostic and therapeutic equipment sector [1] Group 2: Communication and Disclosure - The company encourages investors to refer to its 2025 semi-annual report for detailed information on investments in the high-end medical diagnostic and therapeutic equipment sector [1] - The company will disclose significant information through regular reports or temporary announcements as required [1]

Core Viewpoint - The company, Boshi Co., has made significant investments in high-end medical diagnostic and therapeutic equipment, focusing on three key projects in the field of robotic surgery [2] Investment Projects - The company and its wholly-owned subsidiary have invested in three projects: 1. Harbin Sizerui Intelligent Medical Equipment Co., Ltd. for a minimally invasive laparoscopic surgical robot project 2. Jiangsu Ruil Medical Technology Co., Ltd. for a stereotactic radiosurgery robot project 3. Suzhou Zhuzheng Robot Co., Ltd. for a remote-assisted pedicle screw minimally invasive implantation robot project [2] - Detailed information can be found in the company's 2025 semi-annual report on page 29 under "Investment in High-end Medical Diagnostic and Therapeutic Equipment" [2]

Core Viewpoint - The company, Boshi Co., has confirmed its involvement in the surgical robotics sector through investments in three key projects related to high-end medical diagnostic and therapeutic equipment [1]. Group 1: Company Involvement in Surgical Robotics - Boshi Co. has invested in three projects in the surgical robotics field: 1. Harbin Sizhe Rui Intelligent Medical Equipment Co., Ltd. focusing on minimally invasive laparoscopic surgical robots 2. Jiangsu Ruil Medical Technology Co., Ltd. working on stereotactic radiosurgery robots 3. Suzhou Zhuzheng Robotics Co., Ltd. developing remote-assisted minimally invasive implantation robots [1]. - The details of these investments can be found in the company's 2025 semi-annual report, specifically on page 29 under the section "Investment in High-end Medical Diagnostic and Therapeutic Equipment" [1].

Group 1 - The company has made significant investments in the field of surgical robotics, focusing on high-end medical diagnostic and therapeutic equipment [2] - The company and its wholly-owned subsidiaries are involved in three key projects: a minimally invasive laparoscopic surgical robot project, an image-guided radiation therapy precision positioning project, and a remote-assisted minimally invasive implant robot project [2] - Detailed information regarding these investments can be found in the company's 2024 annual report, specifically on page 39 [2]

Summary of the Conference Call for 博实股份 Company Overview - 博实股份 reported a revenue of 5.033 billion yuan in 2024, a year-on-year increase of 1.59%, with a net profit attributable to shareholders of 524 million yuan, a slight decrease of 1.76% [2][3] - The company focuses on intelligent manufacturing equipment and industrial services, which together account for 93% of its revenue, while environmental process equipment contributes 7% [2][5] Key Business Developments - Significant breakthroughs in the battery production sector were achieved, completing projects for Inner Mongolia Junzheng and Ningxia Yinglit, generating an additional revenue of 320 million yuan [2][6] - The "Robot+" business segment grew rapidly, achieving revenue of 391 million yuan, although costs remained relatively high [2][9] - Revenue from intelligent logistics and warehousing systems saw a drastic decline of 61%, totaling 68.206 million yuan, primarily due to the concentrated acceptance of the G7 project in 2023 [2][11] - Industrial services generated revenue of 768 million yuan, a year-on-year increase of 7.18%, with maintenance and after-sales services contributing significantly [2][12] Financial Performance - In Q1 2025, the company achieved revenue of 700 million yuan, a year-on-year increase of 5.81%, and a net profit of 150 million yuan, up 42% [3][20] - The overall gross margin improved significantly to 40% due to a higher proportion of high-profit products [20][23] Competitive Advantages - 博实股份' core competitiveness lies in its technological leadership, diverse product matrix, strong service capabilities, and industry ecosystem results [5] - The company has established a competitive market position with products like smart workshops and factories, enhancing customer loyalty and risk resilience [5] Future Directions - The company aims to continue executing strategic development in new productive forces and establish benchmarks for smart factories [10][16] - Plans include integrating inspection robots with production lines and developing robotic detection technologies for oil fields [26] International Market Expansion - 博实股份 has made significant progress in international markets, particularly in Southeast Asia, Africa, South America, and Russia, while cautiously managing overseas expansion due to potential U.S. sanctions [27][28] Risk Factors - The company faces several risks, including slower-than-expected advancements in intelligent manufacturing equipment and challenges in expanding industrial services [17][18] Industry Trends - The overall demand for automation upgrades in the chemical industry is expected to improve in 2025 compared to 2024, with a positive outlook for order acquisition [36] Conclusion - 博实股份 maintains a strong foundation and competitive advantages, focusing on automation, digitalization, and intelligent development to ensure sustained growth despite varying international and domestic conditions [37]